文献速递心律失常

房颤消融后卒中和系统性栓塞:EMBOL-AF全球注册研究

Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry.
PubMed 文献 · Eur Heart J · 2026-01-01

多数事件为脑栓塞(94%),78%发生在术后72小时内,非阵发性房颤、中心经验和消融能量来源与栓塞风险相关,3个月随访中35%有后遗症、3%死亡。

要点

  • 房颤消融后症状性栓塞发生率0.16%,但致残致死风险显著
  • 78%栓塞事件发生在术后72小时内,23%在出院后诊断
  • 非阵发性房颤、激光球囊和脉冲场消融与更高栓塞风险相关

核心结论

  • 症状性栓塞事件虽不常见但伴随显著致残率和死亡率。
  • 多数事件发生在早期,但相当比例延迟出现;激光球囊和可能脉冲场消融事件率更高,中心经验更丰富与更低栓塞发生率相关。

研究设计与样本

  • 由欧洲心律协会科学委员会发起的回顾性全球注册研究。

主要发现

  • 总栓塞事件550例,发生率0.16%,中心层面发生率范围0%至3.1%。
  • 事件类型:脑栓塞94%、外周栓塞5%、合并1%;外周事件中冠状动脉空气栓塞占62%。
  • 事件时机:术中93例(17%)、72小时内357例(78%)、72小时后100例(22%);128例(23%)出院后诊断。
  • 非阵发性房颤栓塞率0.23% vs 0.15%(P < .001);消融能量来源事件率:射频0.16%、冷冻球囊0.16%、脉冲场消融0.25%、激光球囊0.88%(P < .001)。
  • 卒中后中位NIHSS评分4(四分位距2-9);3个月随访518例(95%),181例(35%)有后遗症,16例(3%)死亡。

临床怎么用

  • 消融围术期应警惕栓塞事件,尤其术后72小时内。
  • 对非阵发性房颤及使用激光球囊或脉冲场消融的患者加强栓塞风险评估与监测。
  • 中心经验积累可能降低栓塞发生率,应关注手术量与培训。

局限性

  • 回顾性注册研究设计,可能存在报告偏倚和漏报。
  • 仅纳入症状性栓塞事件,无症状事件未捕获。
  • 中心层面发生率差异大,混杂因素未完全校正。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Stroke and systemic embolism are recognized but poorly characterized complications of atrial fibrillation (AF) and left atrial flutter (AFL) catheter ablation. Their incidence, outcomes, and procedural associations remain insufficiently defined. METHODS: Retrospective global registry was initiated by the European Heart Rhythm Association Scientific Committee. A secure database captured data from ablation centres worldwide on general AF and left AFL ablation activity, as well as detailed information on patients with symptomatic embolic events between 2017 and 2024. RESULTS: Overall, 204 centres reported 335 743 ablation procedures and 550 embolic events (incidence 0.16%). Centre-level rate ranged from 0% to 3.1%. Most events were cerebral (94%), followed by peripheral (5%), and combined (1%). Coronary air embolism accounted for 62% of all peripheral events. Intraprocedural events occurred in 93 patients (17%), within 72 h in 357 (78%) and beyond 72 h in 100 (22%); 128 cases (23%) were diagnosed after hospital discharge. Nonparoxysmal AF (0.23% vs 0.15%; P < .001), centre experience, and ablation energy source (radiofrequency, 0.16%; cryoballoon, 0.16%; pulsed field ablation, 0.25%; laserballoon, 0.88%; P < .001) were associated with embolic risk. Median NIHSS score after stroke was 4 (interquartile range, 2-9). Three-month follow-up was available for 518 patients with embolism (95%): 181 (35%) had sequelae and 16 (3%) died. CONCLUSIONS: Symptomatic embolic events are infrequent but associated with significant morbidity and mortality. Most events occur early, though a substantial proportion arise later. Higher event rates were observed with laser and possibly with pulsed field ablation. A greater centre experience was associated with a lower embolism incidence.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Castrejón-Castrejón S, Heeger CH, Veltmann C, et al. Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry. Eur Heart J. 2026. PMID: 41914181. doi:10.1093/eurheartj/ehag217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。